About
Research & Development
Neurodegenerative Diseases
News & Publications
Contact
Who we are
About
PharmatrophiX
About
Our mission, story, and approach.
Leadership
Team, board, and scientific advisors
Peer Reviewed Funding & Investors
Our science
Research &
Development
Research & Development
Our science and development philosophy.
Pipeline
Programs and indications across our development stages.
Monthly Archives: December 2025
p75 receptor modulation slows biomarkers and preserves visuospatial function
Posted on
Dec 2, 2025
CTAD coverage reports p-tau217 and synaptic-proteome signals over 26 weeks....
Read More